Sold in 103 countries worldwide, Grindeks’ product portfolio is successfully composed of branded products, generic medications and active pharmaceutical ingredients, all produced in line with the world class requirements of safety and quality. Our core areas: cardiovascular system, CNS, oncology and diabetes.
